Hypertension Often Hides in Plain Sight: 40,468 Patients Screened in a Fortnight in Alembic’s Record-Breaking Initiative
~The Company Receives Asia Book of Records for Screening 40,468 Patients for Blood Pressure in...
Tag : Alembic pharmaceuticals
Alembic Pharmaceuticals and Amlan International launch MinerTox-Z and MinerTox-A
~These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~ 07 October, 2025:...
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream
18th August 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
28 July, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection
30th June, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Tablets USP, 200 mg
17th April, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Alembic Pharmaceuticals successfully completes USFDA inspection of API-III Facility at Karakhadi
24th March, 2025, Bengaluru: Alembic Pharmaceuticals today announced that it has successfully completed the United States...
Alembic Pharma Reports 4% Revenue Growth; Net Profit at ₹138 Crores in Q3FY25
3rd February 2025, Bengaluru: Alembic Pharmaceuticals Limited reported its consolidated financial results for the third quarter ended...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
15th January, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
20th December, 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...